Further, since type I IFN signaling in the host is also required for protection mediated by NEC immunization, our data support a model in which the initial wave of IFN signal continues to propagate in the host after clearance of dying necroptotic cells to achieve optimal anti-tumor effects. The gene discussed is IFNA1; the disease is neoplasm.